Rydapt (midostaurin)

pCPA File Number: 21181
Negotiation Status:
Negotiations were not pursued
Indication(s):
Systemic Mastocytosis
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
PC0193-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: